Features of the management of bronchial asthma during the COVID-19 pandemic

Abstract

With the emergence of a new disease COVID-19 (CoronaVIrus Disease-2019), caused by the coronavirus SARS-CoV-2, the usual pattern of interaction between a doctor and a patient has changed significantly. During the COVID-19 pandemic, it was assumed that patients with allergies and asthma would be at higher risk of developing severe illness, but after analyzing statistics from different countries, it was concluded that asthma and allergies are not common comorbidities during the COVID-19 pandemic and According to the results of recently published studies, it has not been proven that allergies and allergic asthma are risk factors for exacerbations of asthma caused by the COVID-19 virus, as well as factors for the development of severe COVID-19, and are not factors that increase the risk of death from COVID-19.